Tag: (CSE: IMH; OTC: IVITF; FRA: 8IS)

February 27, 2017

Invictus MD Strategies Corp. Invictus MD announces definitive option agreement with Late Stage Applicant under the ACMPR

Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that further to its news release...
February 15, 2017

Invictus MD's Future Harvest Achieves 63% Increase In Gross Margin For The Past 7 Months Ending January 31, 2017 Compared To Same Period For The Prior Year

VANCOUVER, BC - February 15, 2017 - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: IMH; OTC: IVITF;...
February 10, 2017

Invictus MD Arranges $15.01-million Bought Deal

Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) has entered into an agreement with Canaccord Genuity Corp. and...
February 9, 2017

Invictus MD announce that AB Ventures Inc. has acquired 100 acres for future cannabis cultivation and sale under the ACMPR

Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Ventures Inc. (“AB Ventures”),...
February 8, 2017

Invictus MD Strategies Corp. and Reliq Health Technologies Sign MOU to Collaborate on App for Cannabis Prescribers, Patients and Consumers

VANCOUVER, BC, February 8, 2017 – Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) (“Invictus MD”) is pleased...
February 7, 2017

Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

VANCOUVER, BC, February 7, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA:...